OasisLMS

Course Description
This session provides a practical overview of lung transplant evaluation, focusing on the differences between urgent and outpatient pathways. It reviews candidate selection criteria, common exclusion thresholds, and the role of ECMO in urgent evaluations, along with the structure of standard outpatient workups, including diagnostic testing, multidisciplinary assessment, surgeon consultation, and patient education. Emphasis is placed on coordinated team-based decision-making and preparing patients and caregivers for transplant and post-transplant care.

1. Compare the clinical indications, workflow steps, and decision criteria for urgent versus outpatient lung transplant evaluation pathways, including the role of ECMO in urgent candidate assessment.
2. Identify key eligibility and exclusion factors for lung transplant candidacy -- including age, BMI, tobacco abstinence, and insurance requirements -- and describe the components of a multidisciplinary evaluation and patient preparation process.
   
   

Kathryn Hughes, MSN, APRN, AGACNP, Vanderbilt Medical Center, Nashville, TN, USA (Chair)
Meg Fregoso, MSN, NP-BC, CCTC, Inova Fairfax Hospital, Falls Church, VA, USA (Chair)
Megan Harvey, RN, BSN, Inova Fairfax Hospital, Falls Church, VA, USA
Breah Paciotti, MPH, PA-C, FAPACVS, Mayo Clinic Florida, Jacksonville, FL, USA

Faculty Disclosures

The Heart Failure Society of America (HFSA) and the International Society for Heart and Lung Transplantation (ISHLT) are committed to ensuring balance, independence, objectivity, and scientific rigor in its educational activities. HFSA has a disclosure policy that requires oral presenters to disclose all relevant financial relationships for themselves and their spouse or partner during the past 24-months with any commercial entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients and related to the content of the activity, whether or not these commercial entities are supporters of the activity. 

  
Speakers will have a disclosure slide at the beginning of each presentation. All potential conflicts of interest have been resolved in accordance with the ACCME Updated Standards for Commercial Support. 

The following faculty and/or accreditors with ability to control content for this activity have no conflict of interest: 

Kathryn Hughes, MSN, APRN, AGACNP
Meg Fregoso, MSN, NP-BC, CCTC
Megan Harvey, RN, BSN
Breah Paciotti, MPH, PA-C, FAPACVS

Off-Label Disclosure 

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.